330 related articles for article (PubMed ID: 27764985)
1. Adiponectin, leptin, nitric oxide, and C-reactive protein levels in kidney transplant recipients: comparison with the hemodialysis and chronic renal failure.
Ocak N; Dirican M; Ersoy A; Sarandol E
Ren Fail; 2016 Nov; 38(10):1639-1646. PubMed ID: 27764985
[TBL] [Abstract][Full Text] [Related]
2. Adipocytokines leptin and adiponectin, and measures of malnutrition-inflammation in chronic renal failure: is there a relationship?
Dervisoglu E; Eraldemir C; Kalender B; Kir HM; Caglayan C
J Ren Nutr; 2008 Jul; 18(4):332-7. PubMed ID: 18558297
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic kidney disease and type of dialysis on serum levels of adiponectin, TNF-alpha and high sensitive C-reactive protein.
Kir HM; Eraldemir C; Dervisoglu E; Caglayan C; Kalender B
Clin Lab; 2012; 58(5-6):495-500. PubMed ID: 22783580
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory markers and hepatocyte growth factor in sustained hemodialysis hypotension.
Lee CT; Hsu CY; Lam KK; Lin CR; Chen JB
Artif Organs; 2005 Dec; 29(12):980-3. PubMed ID: 16305655
[TBL] [Abstract][Full Text] [Related]
5. Relationship between epicardial adipose tissue, inflammation and volume markers in hemodialysis and transplant patients.
Çolak H; Kilicarslan B; Tekce H; Tanrisev M; Tugmen C; Aktas G; Kursat S
Ther Apher Dial; 2015 Feb; 19(1):56-62. PubMed ID: 25628169
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: are they related?
Malyszko J; Malyszko J; Wolczynski S; Mysliwiec M
Nephrol Dial Transplant; 2006 Jan; 21(1):145-52. PubMed ID: 16141459
[TBL] [Abstract][Full Text] [Related]
7. The relationship between inflammatory markers, leptin and adiponectin in chronic hemodialysis patients.
Lee CT; Lee CH; Su Y; Chuang YC; Tsai TL; Cheni JB
Int J Artif Organs; 2004 Oct; 27(10):835-41. PubMed ID: 15560677
[TBL] [Abstract][Full Text] [Related]
8. Association of adiponectin and leptin with serum lipids and erythrocyte omega-3 and omega-6 fatty acids in dialysis patients.
An WS; Son YK; Kim SE; Kim KH; Bae HR; Lee S; Park Y; Kim HJ; Vaziri ND
Clin Nephrol; 2011 Mar; 75(3):195-203. PubMed ID: 21329629
[TBL] [Abstract][Full Text] [Related]
9. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
[TBL] [Abstract][Full Text] [Related]
10. Comparison of markers of appetite and inflammation between hemodialysis patients with and without failed renal transplants.
Caliskan Y; Yelken B; Gorgulu N; Ozkok A; Yazici H; Telci A; Turkmen A; Yildiz A; Sever MS
J Ren Nutr; 2012 Mar; 22(2):258-267. PubMed ID: 22056149
[TBL] [Abstract][Full Text] [Related]
11. The plasma leptin/adiponectin ratio predicts first cardiovascular event in men: a prospective nested case-control study.
Kappelle PJ; Dullaart RP; van Beek AP; Hillege HL; Wolffenbuttel BH
Eur J Intern Med; 2012 Dec; 23(8):755-9. PubMed ID: 22819464
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease.
Díez JJ; Iglesias P; Fernández-Reyes MJ; Aguilera A; Bajo MA; Alvarez-Fidalgo P; Codoceo R; Selgas R
Clin Endocrinol (Oxf); 2005 Feb; 62(2):242-9. PubMed ID: 15670203
[TBL] [Abstract][Full Text] [Related]
13. Changes in the inflammatory and oxidative stress markers during a single hemodialysis session in patients with chronic kidney disease.
Sangeetha Lakshmi B; Harini Devi N; Suchitra MM; Srinivasa Rao PVLN; Siva Kumar V
Ren Fail; 2018 Nov; 40(1):534-540. PubMed ID: 30277113
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk assessment and homocysteine and leptin levels in peritoneal dialysis and hemodialysis patients.
Bekpinar S; Unlüçerçi Y; Genç S; Türkmen A
Adv Perit Dial; 2005; 21():80-4. PubMed ID: 16686291
[TBL] [Abstract][Full Text] [Related]
15. Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients.
Zoccali C; Tripepi G; Cambareri F; Catalano F; Finocchiaro P; Cutrupi S; Pizzini P; Testa A; Spoto B; Panuccio V; Enia G; Mallamaci F
J Ren Nutr; 2005 Jan; 15(1):125-30. PubMed ID: 15648021
[TBL] [Abstract][Full Text] [Related]
16. Salivary markers in patients with chronic renal failure.
Pallos D; Leão MV; Togeiro FC; Alegre L; Ricardo LH; Perozini C; Ruivo GF
Arch Oral Biol; 2015 Dec; 60(12):1784-8. PubMed ID: 26451646
[TBL] [Abstract][Full Text] [Related]
17. Adipokines, endothelial dysfunction and nutritional status in peritoneal dialysis patients.
Małgorzewicz S; Lichodziejewska-Niemierko M; Aleksandrowicz-Wrona E; Świetlik D; Rutkowski B; Łysiak-Szydłowska W
Scand J Urol Nephrol; 2010 Dec; 44(6):445-51. PubMed ID: 20624111
[TBL] [Abstract][Full Text] [Related]
18. The effects of renal replacement therapy on plasma, asymmetric dimethylarginine, nitric oxide and C-reactive protein levels.
Uzun H; Konukoglu D; Besler M; Erdenen F; Sezgin C; Muderrisoglu C
Clin Invest Med; 2008; 31(1):E1-7. PubMed ID: 18312743
[TBL] [Abstract][Full Text] [Related]
19. Association of malnutrition-inflammation score, dialysis-malnutrition score and serum albumin with novel risk factors for cardiovascular diseases in hemodialysis patients.
As'habi A; Tabibi H; Hedayati M; Mahdavi-Mazdeh M; Nozary-Heshmati B
Ren Fail; 2015 Feb; 37(1):113-6. PubMed ID: 25296104
[TBL] [Abstract][Full Text] [Related]
20. Effects of lipoprotein-associated phospholipase A2 on arginase/nitric oxide pathway in hemodialysis patients.
Tektaş AK; Uslu S; Yalçin AU; Sahin G; Temiz G; Kara M; Temel HE; Demirkan ES; Colak E; Colak O
Ren Fail; 2012; 34(6):738-43. PubMed ID: 22583316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
